Effect of Chinese traditional compound, Gan-fu-kang, on CCl4-induced liver fibrosis in rats and its probable molecular mechanisms

Hepatology Research

Volumn 37, Issue 3, 2007, Pages 221-229

  Xu, Ting Ting ^a   Jiang, Miao Na ^a   Li, Cong ^a   Che, Ying ^a   Jia, Yu Jie ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Gan fu kang; Liver fibrosis; MMP 2; TGF 1; TIMP 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CHINESE DRUG; COLCHICINE; GAN FU KANG; GELATINASE A; HYDROXYPROLINE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME ASSAY; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER FUNCTION; LIVER LEVEL; LOW DRUG DOSE; NONHUMAN; POLARIZATION MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 33947187745     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00029.x     Document Type: Article

References (31)

1. Bedossa P, Paradis V. Liver extracellular matrix in health and disease. J Pathol 2003; 200: 504-515.
2. Friedman SL. Molecular regulation of Hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-50.
3. Sun YF, Yao XX, Jiang SL. The traditional Chinese medicine treatment of liver fibrosis. Shijie Huaren Xiaohua Zazhi 2000; 8: 686-7.
4. Liu CH, Hu YY, Wang XL, Liu P, Xu LM. Effects of salvianolic acid-A on NIH/3T3 fibroblast proliferation, collagen synthesis and gene expression. World J Gastroenterol 2000; 6: 361-4.
5. Wu X-L, Zeng W-Z, Wang P-L et al. Effect of compound rhodiola sachalinensis A Bor on CCl4-induced liver fibrosis in rats and its probable molecular mechanisms. World J Gastroenterol 2003; 9: 1559-62.
6. Song S-L, Gong Z-J, Zhang Q-R, Huang T-X. Effects of Chinese traditional compound, JinSanE, on expression of TGF-β1 and TGF-β1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo. World J Gastroenterol 2005; 11: 2269-76.
7. Yang W, Zeng M, Fan Z et al. Prophylactic and therapeutic effect of oxymatrine on d-galactosamine-induced rat liver fibrosis. Zhonghua Ganzangbing Zazhi 2002; 10: 193-6.
8. Wang H, Wei W, Wang N-P et al. Effects of total glucosides of peony on immunological hepatic fibrosis in rats. World J Gastroenterol 2005; 11: 2124-9.
9. Dang S-S, Jia X-L, Cheng Y-A, Chen Y-R, Liu E-Q, Li Z-F. Inhibitory effect of Huangqi Zhechong decoction on liver fibrosis in rat. World J Gastroenterol 2004; 10: 2295-8.
10. Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol 1996; 8: 618-24.
11. Rojkind M, Giambrone MA, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979; 76: 710-19.
12. Hahn E, Wick G, Pencev D, Timpl R, et al. Distribution of basement membrane proteins in normal and fibrotic human liver collagen type IV, laminin, and fibronectin. Gut 1980; 21: 63-71.
13. Bissell DM, Choun MO. The role of extracellular matrix in normal liver. Scand J Gastroenterol 1988; 23 (Suppl 151): 1-7.
14. Xu G-F, Wang X-Y, Ge G-L et al. Dynamic changes of capillarization and peri-sinusoid fibrosis in alcoholic liver diseases. World Gastroenterol 2004; 10: 238-243.
15. Knittel T, Mehde M, Kobold D, Saile B, Dinter C, Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: Regulation by TNF-a and TGF-h1. J Hepatol 1999; 30: 48-60.
16. Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996; 110: 821-31.
17. Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001; 21: 373-84.
18. Galli A, Svegliati-Baroni G, Ceni E et al. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology 2005; 41: 1074-84.
19. Takahara T, Furui K, Funaki J et al. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology 1995; 21: 787-95.
20. Lichtinghagen R, Breitenstein K, Arndt B, Kuhbacher T, B-ker KHW. Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver. Virchows Arch 1998; 432: 153-8.
21. Murphy G, Hembry RM, Hughes CE, Fosang AJ, Hardingham TE. Role and regulation of metalloproteinases in connective tissue turnover. Biochem Soc Trans 1990; 18: 812-15.
22. Herbst H, Wege T, Milani S et al. Tissue inhibitor of metalloproteinase-1 and 2 RNA expression in rat and human liver fibrosis. Am J Pathol 1997; 150: 1647-59.
23. Murawaki Y, Ikuta Y, Kawasaki H. Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1. Clin Chim Acta 1999; 281: 109-20.
24. Murawaki Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H. Tissue inhibitor of metalloproteinase 1 in the liver of patients with chronic liver disease. J Hepatol 1997; 26: 1213-19.
25. Casini A, Ceni E, Salzano R, Milani S, Schuppan D, Surrenti C. Acetaldehyde regulates the gene expression of matrixmetalloproteinase-1 and 2 in human fat storing cells. Life Sci 1994; 55: 1311-16.
26. Iredale JP, Benyon RC, Pickering J et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538-49.
27. Tahashi Y, Matsuzaki K, Date M et al. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 2002; 35: 49-61.
28. Napoli J, Prentice D, Niinami C, Bishop GA, Desmond P, McCaughan GW. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology 1997; 26: 624-33.
29. Le Pabic H, Bonnier D, Wewer UM et al. ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 2003; 37: 1056-66.
30. Cui X, Shimizu I, Lu G et al. Inhibitory effect of a soluble transforming growth factor beta type II receptor on the activation of rat hepatic stellate cells in primary culture. J Hepatol 2003; 39: 731-7.
31. Gaca MD, Zhou X, Issa R, Kiriella K, Iredale JP, Benyon RC. Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: Evidence for matrix-dependent deactivation of stellate cells. Matrix Biol 2003; 22: 229-39.